Europe Digital Health Ecosystem 2023 Mid Year Report

Don’t miss the Europe H1 2023 Key Trends in Digital Health with this semi-annual report on the current state and future outlook of the global Digital Health ecosystem. As Europe jumps into second place for venture funding in Digital Health, it has already established itself as a focused and mature ecosystem, capturing the top spot globally for ventures with Clinical Evidence.

The Europe H1 2023 Key Trends report focuses on private ventures and includes current trends, ecosystem development, most active partners, and venture funding.

  • $1.38B of venture funding was deployed in H1 2023 to ventures founded in Europe, a decline of 53% from H1 2022.
  • Europe has moved into the top spot across the globe for Clinical Evidence, with 22% of all ventures attaining a significant level of Clinical Evidence, indicating that the ventures’ Digital Health solutions can improve the outcomes of the patient population that is being addressed
  • After taking second place to France in 2022, the United Kingdom is back to leading venture funding in Europe in H1 2023, capturing 32% of venture funding value.
  • … and much more

The “Europe Digital Health Innovation Ecosystem Report on H1 2023 Key Trends” report includes data on the following companies: Baseimmune, Doctorly, Alba Health, Gleamer, Phlo, Roche, AstraZeneca, Novartis, Pfizer, Cyted, Nye Health, SOPHiA GENETICS, BenevolentAI, Alex Therapeutics, Volta Medical, Distalmotion, Alentis Therapeutics, Patient21, Peppy, Caristo Diagnostics, Memodio, Perspectum Diagnostics, EBAMed, Skin + Me, Deeplink Medical, Dxcover, Nelly, InFlow, Haystack Oncology, Diamond Whites, Maela, UgenTec, Blackford Analytics, Bayer AG, Nouveal, Jefferson Health, Ada Health, RetinAI Medical, AIG, MediQuo, Gaia, Chugai Pharmaceutical

HealthTech Alpha, a Galen Growth proprietary solution, powers this report!

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit to learn more about our data or research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit

HEADLINES: 10 pages, 6 charts, 5 tables  
ECOSYSTEM INSIGHTS: 5 pages, 8 charts, 5 tables  
INVESTMENT INSIGHTS: 7 pages, 7 charts, 1 table  
CLUSTER FOCUS: 4 pages, 2 charts, 1 table  
THERAPEUTIC FOCUS: 3 pages, 2 charts, 1 table  
DEEP DIVES: 21 pages, 24 charts, 4 tables  
NOTEWORTHY: 4 pages, 3 tables  

Buy Only


  • Purchase and download this report
  • Access to limited data in HealthTech Alpha
Buy Now


  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Custom Solution


  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2024




Total Funding

GGA Score

powered by